NEJM: Trial of A Monoclonal Antibody to PACAP for Migraine Prevention

Posted Wednesday, September 4, 2024 7:17 pm

PainRelief.com (via Pain Relief at PainRelief.com)

PainRelief.com Interview with:Professor Messoud Ashina, MD, PhD, DMScDepartment of Neurology and Danish Headache CenterGlostrup HospitalUniversity of Copenhagen, GlostrupCopenhagen, Denmark PainRelief.com: What is the background for this study? Background and Main Findings: Current migraine treatments targeting CGRP aren’t fully effective for everyone. PACAP is another key molecule implicated in migraine and can trigger migraine attacks. Lu AG09222, an antibody that blocks PACAP, has shown promise in reducing migraine days in a phase 2a trial. Effects Duration: 4 weeks. Last Updated on September 4, 2024 by PainRelief.com

Continue reading at Pain Relief at PainRelief.com »

Keywords

Migraine, #headache, #migraine, #pain, #painrelief

Top stories

How Psoriasis Stigma Impacts Health

(National Psoriasis Foundation) - You’ve seen the commercials. Psoriasis treatments are everywhere. So it would follow that people with psoriasis can also be found everywhere, right? In theory, …

Prepárate ahora para protegerte durante la temporada de enfermedades respiratorias

(NewsUSA) - Los niños están regresando a la escuela y el otoño se acerca rápidamente, lo que significa que la temporada de enfermedades respiratorias está a la vuelta de la esquina. Los …

Prepare Now to Protect Yourself During Respiratory Illness Season

(NewsUSA) - Children are returning to school and fall is fast approaching, which means respiratory illness season is right around the corner. Health experts urge that now is the time to think about …

Bid Farewell to Toenail Fungus from the Comfort of Your Home

(NewsUSA) - Say hello to the uninvited guest: toenail fungus, the ultimate party crasher for your confidence! It’s not just about feeling uneasy; it’s like a fashion police for your feet, …

Back-to-School Essential: Protection Against Meningitis

(Amy Pisani) - The summer heat still lingers, but parents and caregivers have embarked on the annual ritual of preparing children for the school year ahead. Store shelves overflow with school …

From the web

BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports TNX-801 Aligns with WHO Preferred TPP for Mpox Vaccines

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated biopharmaceutical company with marketed products and a pipeline of development candidates, is reporting that the World Health Organization’s …

TinyGemsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Reports on Offering Valued at Approximately $3.4M Offering

Vision Marine Technologies (NASDAQ: VMAR), a pioneer in electric marine propulsion, is reporting on the pricing of a best-efforts offering. The offering is comprised of 3,400,000 common shares, with …

A Crystal Ball for Cancer Survivors

This test can be thought of as a crystal ball for cancer survivors and research has found it can predict with near certainty whether a patient’s cancer will recur. So why aren’t more patients …

InvestorNewsBreaks – WiSA Technologies Inc.’s (NASDAQ: WISA) Partner Data Vault to Showcase Its PhytoIntel Digital Twins Platform at NYSDS 2024

WiSA Technologies (NASDAQ: WISA), a leading provider of immersive, wireless sound technology for intelligent devices and next-generation home entertainment systems, recently entered into a definitive …

We’re Overcomplicating Healthcare AI — Here’s How We Achieve Impact Beyond The Hype

It’s important that we focus attention on the areas where AI is already having a significant impact. These are the practical applications that will allow the best and brightest researchers to focus …